BioSpace News Archive

BrainStorm announced today the appointment of Anthony Polverino, Ph.D., to its board of directors. Dr. Polverino is a highly accomplished senior biopharma executive with more than 25 years’ industry experience in drug research and development.

Teleflex Incorporated, a leading global provider of medical technologies for critical care and surgery, has announced 510(k) clearance by the Food and Drug Administration and U.S. commercial launch of new versions of its Expro Elite and Sympro Elite Snares for manipulating interventional devices in peripheral procedures.

The study of RV521, an oral RSV fusion inhibitor, achieved all its primary and secondary endpoints (significantly reduced viral load, reduced total mucus weight and reduced clinical symptoms) compared to placebo.

Following the allocation, Malene Brondberg holds 20 000 PSUs, 0 options and 0 shares in Nordic Nanovector.

Amneal Pharmaceuticals has launched methylphenidate hydrochloride extended-release tablets, USP in 18, 27, 36, and 54 mg strengths.

Under this Agreement, IROA Technologies and SCIEX will promote a unique measurement system called the IROA Workflow with SWATH Acquisition based on next-generation metabolomics and TripleTOF Systems.

Mr. Walsh currently serves as the Executive Vice President and Chief Financial Officer at Catalent, a role he assumed in 2008.

The improved new generation InMotion Arm will provide the same innovative active-assisted robotic therapy, but with a new industrial design that is modern, smaller and sleeker.

Bristol-Myers Squibb posted fourth quarter 2017 revenues of $5.4 billion, an increase of 4% compared to the same period a year ago.

CTI BioPharma today announced the launch of a proposed underwritten public offering of shares of its common stock.